Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Leukemia

Free Subscription 01.12.2025 1 Acta Haematol 1 Am J Hematol 1 Biochem Biophys Res Commun 1 Blood 2 BMC Cancer 3 Bone Marrow Transplant 1 Eur J Haematol 1 Int J Hematol 1 Leuk Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. THOMPSON J, Thompson JF, Grose R, Yeung D, et al
   Direct STAT3 and STAT5 Inhibition Overcomes Treatment Resistance in a Murine-Derived in vitro Model of Acute Lymphoblastic Leukaemia Driven by ETV6::JAK2.
   Acta Haematol. 2025;148:729-733.
   PubMed         Abstract available
   
   

   
   Am J Hematol

2. MOLICA M, Miralles G, Dillon R, Annunziata M, et al
   Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients.
   Am J Hematol. 2025 Nov 22. doi: 10.1002/ajh.70142.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. SHIMURA R, Yamamoto K, Chang YH, Otaki A, et al
   Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.
   Biochem Biophys Res Commun. 2025;793:153002.
   PubMed         Abstract available
   
   

   
   Blood

4. 
   Yeung DT, Shanmuganathan N, Reynolds J, et al; Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study. Blood. 2024;144(19):1993-2001.
   Blood. 2025;146:2729.
   PubMed        
   
   

   
   BMC Cancer

5. IDREES N, Rana NF, Tariq U, Fatima S, et al
   Nanoencapsulation of ferrocene incorporated thiourea and doxorubicin for treatment of acute myeloid leukemia.
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15006.
   PubMed        
   
   
6. AL KUWARI H, Al Khinji A, Al-Hamed D, Al Hor A, et al
   NOTCH1 mutation status as a prognostic biomarker in T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.
   BMC Cancer. 2025;25:1820.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

7. SANZ J, Ferhat AT, Raiola AM, Blaise D, et al
   Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT.
   Bone Marrow Transplant. 2025 Nov 25. doi: 10.1038/s41409-025-02763.
   PubMed         Abstract available
   
   
8. AL-ALI RW, Gui G, Ravindra N, Andrew G, et al
   Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.
   Bone Marrow Transplant. 2025 Nov 24. doi: 10.1038/s41409-025-02757.
   PubMed        
   
   
9. BARBULLUSHI K, Labopin M, Kroger N, Finke J, et al
   Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT.
   Bone Marrow Transplant. 2025 Nov 21. doi: 10.1038/s41409-025-02740.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

10. MARTINO EA, Caserta S, Vigna E, Bruzzese A, et al
    Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies.
    Eur J Haematol. 2025 Nov 25. doi: 10.1111/ejh.70065.
    PubMed         Abstract available
    
    

    
    Int J Hematol

11. FUJI S, Ohmoto A
    Current status of hematopoietic cell transplantation in patients with peripheral T-cell lymphoma including adult T-cell leukemia-lymphoma.
    Int J Hematol. 2025 Nov 24. doi: 10.1007/s12185-025-04118.
    PubMed         Abstract available
    
    

    
    Leuk Res

12. JAIN P, Qazi I, Thompson J, Ganatra N, et al
    Neutropenic enterocolitis in acute myeloid leukemia: A nationwide inpatient cross-sectional study.
    Leuk Res. 2025;160:108142.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.